BioCision was founded in 2007 by Rolf Ehrhardt and Brian Schryver when they realized, having spent many years in the clinical and laboratory environment, that there were critical unmet needs in the handling of temperature-sensitive biospecimens and biologics.

The rapid adoption of their first product—CoolRack thermo-conductive modules—confirmed their assumptions. Customers quickly began asking for different formats, and the BioCision cooling product platform quickly grew, eventually evolving into the new BioT (Bio-Transport) temperature stability systems.

The company’s CoolCell passive controlled-rate cell freezing platform replaced outdated methods of using alcohol to slow freezing rates, and became the standard for passive cell freezing around the world. It was adopted by ATCC, the largest biorepository for authenticated biological materials.

 …